Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas

Synapse

Volumn 65, Issue 4, 2011, Pages 278-286

  Heng, Lijun ^a   Beverley, Joel A ^a   Steiner, Heinz ^a   Tseng, Kuei Y ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Adolescence; CB1 cannabinoid receptor; Gene expression; Prefrontal cortex

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; ELECTROPHYSIOLOGY; GENE EXPRESSION; JUVENILE; LIMBIC CORTEX; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR CORTEX; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

AGE FACTORS; ANIMALS; ASSOCIATION LEARNING; GENE EXPRESSION REGULATION; LIMBIC SYSTEM; MALE; MOTOR CORTEX; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SOMATOSENSORY CORTEX;

EID: 79251590548     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20844     Document Type: Article

References (40)

1. Andersen SL. 2003. Trajectories of brain development: Point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27: 3-18.
2. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T. 2007. Hardwiring the brain: Endocannabinoids shape neuronal connectivity. Science 316: 1212-1216.
3. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF. 2005. Endocannabinoid signaling in rat somatosensory cortex: Laminar differences and involvement of specific interneuron types. J Neurosci 25: 6845-6856.
4. Bunge SA, Wright SB. 2007. Neurodevelopmental changes in working memory and cognitive control. Curr Opin Neurobiol 17: 243-250.
5. Casey BJ, Giedd JN, Thomas KM. 2000. Structural and functional brain development and its relation to cognitive development. Biol Psychol 54: 241-257.
6. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW. 2005. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57: 1117-1127.
7. Chambers RA, Taylor JR, Potenza MN. 2003. Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. Am J Psychiatry 160: 1041-1052.
8. D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH. 2005. Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biol Psychiatry 57: 594-608.
9. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. 2004. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology 29: 1558-1572.
10. Devane WA, Dysarz FAIII, Johnson MR, Melvin LS, Howlett AC. 1988. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613.
11. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. 2009. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19: 220-230.
12. Eggan SM, Lewis DA. 2007. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: A regional and laminar analysis. Cereb Cortex 17: 175-191.
13. Ellgren M, Artmann A, Tkalych O, Gupta A, Hansen HS, Hansen SH, Devi LA, Hurd YL. 2008. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol 18: 826-834.
14. Fortin DA, Levine ES. 2007. Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb Cortex 17: 163-174.
15. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF, 3rd, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101: 8174-8179.
16. Harkany T, Guzman M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K. 2007. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28: 83-92.
17. Harkany T, Mackie K, Doherty P. 2008. Wiring and firing neuronal networks: Endocannabinoids take center stage. Curr Opin Neurobiol 18: 338-345.
18. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10: 40-68; image 45.
19. Henquet C, Murray R, Linszen D, van Os J. 2005. The environment and schizophrenia: The role of cannabis use. Schizophr Bull 31: 608-612.
20. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11: 563-583.
21. Kreitzer AC, Regehr WG. 2002. Retrograde signaling by endocannabinoids. Curr Opin Neurobiol 12: 324-330.
22. Leslie FM, Loughlin SE, Wang R, Perez L, Lotfipour S, Belluzzia JD. 2004. Adolescent development of forebrain stimulant responsiveness: Insights from animal studies. Ann N Y Acad Sci 1021: 148-159.
23. Lovinger DM. 2008. Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol: 435-477.
24. Luna B, Garver KE, Urban TA, Lazar NA, Sweeney JA. 2004. Maturation of cognitive processes from late childhood to adulthood. Child Dev 75: 1357-1372.
25. Mailleux P, Vanderhaeghen JJ. 1992. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48: 655-668.
26. Matsuda LA, Bonner TI, Lolait SJ. 1993. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535-550.
27. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. 2007. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 370: 319-328.
28. Mulder J, Aguado T, Keimpema E, Barabas K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzman M, Lu HC, Galve-Roperh I, Harkany T. 2008. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci U S A 105: 8760-8765.
29. O'Brien MS, Anthony JC. 2005. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 30: 1006-1018.
30. Pantelis C, Yucel M, Wood SJ, Velakoulis D, Sun D, Berger G, Stuart GW, Yung A, Phillips L, McGorry PD. 2005. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 31: 672-696.
31. Paxinos G, Watson C. 1998 The rat brain in stereotaxic coordinates. New York: Academic Press.
32. Realini N, Rubino T, Parolaro D. 2009. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacol Res 60: 132-138.
33. Segalowitz SJ, Davies PL. 2004. Charting the maturation of the frontal lobe: an electrophysiological strategy. Brain Cogn 55: 116-133.
34. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J. 2002. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287: 1123-1131.
35. Spear LP. 2000. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
36. Steiner H, Kitai ST. 2000. Regulation of rat cortex function by D1 dopamine receptors in the striatum. J Neurosci 20: 5449-5460.
37. Thomson AM. 2000. Facilitation, augmentation and potentiation at central synapses. Trends Neurosci 23: 305-312.
38. Tseng KY, O'Donnell P. 2004. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24: 5131-5139.
39. Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660-669.
40. Woo TU, Pucak ML, Kye CH, Matus CV, Lewis DA. 1997. Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience 80: 1149-1158.